Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry sheeba farhat25 April 2026 5:06 PM ISTNew Delhi: Swiss drugmaker Roche's first-quarter sales dropped by 5%, it said on Thursday, citing unfavourable foreign exchange effects that offset...
Roche Submits Fenebrutinib for MS Approval, Reports Improved Relapse Control Amid Death Cases sheeba farhat22 April 2026 10:00 AM ISTNew Delhi: Swiss drugmaker Roche on Wednesday said it was submitting its experimental multiple sclerosis drug fenebrutinib to global regulators after...
Boehringer Ingelheim to Set Up AI-Driven Drug Discovery Centre in London sheeba farhat21 April 2026 11:29 PM ISTBengaluru: German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning in London, it said on...
Roche Restarts Phase III Trial for Elevidys to Secure EMA Approval sheeba farhat17 April 2026 4:14 PM ISTNew Delhi: Roche on Thursday said it is initiating a late stage study for its gene therapy Elevidys following feedback from the European drug...
C4 Therapeutics, Roche Ink USD 1 Billion Cancer Drug Deal for Novel DAC Therapies sheeba farhat12 April 2026 10:30 AM ISTNew Delhi: C4 Therapeutics, opens new tab said on Thursday it has entered into a deal focused on research and development of a type of cancer drug...
Roche Drops Muscle Disease Drug After Trial Failure sheeba farhat23 March 2026 11:30 AM ISTBengaluru: Roche has stopped developing its experimental drug for two rare muscle diseases after it failed to show meaningful benefits, the Swiss...
Mankind Pharma Acquires Rivotril Brand from Roche to Boost CNS Portfolio in India Parthika Patel20 March 2026 11:48 PM ISTNew Delhi: Mankind Pharma Limited has acquired the Rivotril brand from Roche for the Indian market, securing exclusive rights to manufacture, market...
Roche Expands AI Capabilities with 2,100+ Nvidia Chips to Accelerate Drug Development sheeba farhat17 March 2026 10:30 PM ISTBerlin: Swiss drugmaker Roche said on Monday it had expanded its artificial intelligence computing capacity with more than 2,100 Nvidia chips to...
Roche Aims to Build Affordable, Tolerable Obesity Drug Portfolio: Genentech CEO sheeba farhat17 March 2026 6:00 PM ISTNew York: Roche's Ashley Magargee, chief executive of its Genentech unit, said on Monday the company is striving to build a portfolio of obesity...
Roche Breast Cancer Drug Giredestrant Fails Late-Stage Trial Goal sheeba farhat10 March 2026 10:56 PM ISTFrankfurt: Roche's shares dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising breast cancer drug candidate...
Roche's Experimental Obesity Drug Delivers Up to 22.5% Weight Loss in Phase-II Trial sheeba farhat28 Jan 2026 4:46 PM ISTRoche's experimental obesity drug CT-388 reduces appetite and is in the same class as Lilly's market-leading Zepbound, also known as tirzepatide and...
Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma Ruchika Sharma22 Dec 2025 2:30 PM ISTBasel: Roche has received approval from the US Food and Drug Administration (FDA) for CD20xCD3 bispecific Lunsumio VELO (mosunetuzumab), as a...
